Category: hematologic malignancies
Bromodomain Inhibitors: What Does the Future Hold?
Abstract: Cancer cells are addicted to mutations that cause gain of function in oncogenes and loss of function in tumor suppressors, so that these cells […]
Advances in the Management of Fungal Infections
H&O What are the most common fungal infections among patients with hematologic malignancies? MM We are increasingly forced to confront this issue because some treatments […]